Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment Due to Alzheimer's Disease”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Testing effectiveness (Phase 2)Study completedNCT04032626
What this trial is testing

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Who this might be right for
Cognitive Impairment, MildCognitive DysfunctionAmyloid Plaque+2 more
St. Joseph's Hospital and Medical Center, Phoenix 15
Large-scale testing (Phase 3)Ended earlyNCT02284906
What this trial is testing

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 40
Early research (Phase 1)Ended earlyNCT02573740
What this trial is testing

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
AbbVie 8
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Not applicableNot Yet RecruitingNCT06761066
What this trial is testing

Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Who this might be right for
Alzheimer Disease
NVP Healthcare 60
Testing effectiveness (Phase 2)Study completedNCT02423200
What this trial is testing

Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Alzheimer's Disease
EIP Pharma Inc 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT06182085
What this trial is testing

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
PRInnovation GmbH 304
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Testing effectiveness (Phase 2)UnknownNCT04141150
What this trial is testing

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics, LLC 130
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Ended earlyNCT03639987
What this trial is testing

Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

Who this might be right for
Cognitive DysfunctionAlzheimer's Disease
Biogen 52
Testing effectiveness (Phase 2)Looking for participantsNCT06489548
What this trial is testing

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Who this might be right for
DementiaAlzheimers DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Brigham and Women's Hospital 16
Not applicableActive Not RecruitingNCT05732519
What this trial is testing

Turkish Speech Analysis Development Study

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
mihrimah ozturk 180
Testing effectiveness (Phase 2)Study completedNCT05104463
What this trial is testing

CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentDementia
CuraSen Therapeutics, Inc. 64
Early research (Phase 1)Study completedNCT05681819
What this trial is testing

Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients.

Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 33
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Load More Results